Predictive value of HER-2 and Topoisomerase IIα in response to primary doxorubicin in breast cancer
Open Access
- 30 November 2006
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 42 (17), 2954-2960
- https://doi.org/10.1016/j.ejca.2006.06.013
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative GroupJournal of Clinical Oncology, 2005
- Chromogenic In Situ Hybridization for the Detection of HER-2/neuGene Amplification in Breast Cancer With an Emphasis on Tumors With Borderline and Low-Level AmplificationAmerican Journal of Clinical Pathology, 2005
- Correlation between HER‐2 expression and response to neoadjuvant chemotherapy with 5‐fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinomaCancer, 2003
- Topoisomerase II-α (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapyEuropean Journal Of Cancer, 2003
- Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinomaCancer, 2002
- Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancerBritish Journal of Cancer, 2002
- Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome VariablesLaboratory Investigation, 2000
- ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapyEuropean Journal Of Cancer, 2000
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987